Abstract |
In December of 2002, the FDA approved azelaic acid 15% gel for the topical treatment of inflammatory papules and pustules of mild to moderate rosacea. Azelaic acid is a saturated dicarboxylic acid, which is naturally occurring and has been used in the treatment of rosacea, acne, and melasma. The 15% gel has a high efficacy and is generally well tolerated, with the local irritation (burning, stinging, itching, and scaling) being typically mild and transient. Azelaic acid 15% gel is considered effective and safe as a therapy for inflammatory papulo-pustular rosacea and is suitable for use on all skin types.
|
Authors | Aditya K Gupta, Melissa D Gover |
Journal | International journal of dermatology
(Int J Dermatol)
Vol. 46
Issue 5
Pg. 533-8
(May 2007)
ISSN: 0011-9059 [Print] England |
PMID | 17472690
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
|
Chemical References |
- Dermatologic Agents
- Dicarboxylic Acids
- Gels
- Ointments
- azelaic acid
|
Topics |
- Dermatologic Agents
(adverse effects, therapeutic use)
- Dicarboxylic Acids
(adverse effects, therapeutic use)
- Gels
- Humans
- Ointments
- Randomized Controlled Trials as Topic
- Rosacea
(drug therapy)
- Treatment Outcome
|